CHICAGO, May 15, 2025--(BUSINESS WIRE)--MAIA Biotechnology ... data from the Phase 2 THIO-101 clinical trial was accepted for poster presentation at the 2025 Annual Meeting of the American ...

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 ...

April 30, 2025--(BUSINESS WIRE)--PanGIA Biotech, a company advancing urine ... 3080), has been accepted for presentation in the poster session titled Developmental Therapeutics—Molecularly ...

Siren Biotechnology Inc., pioneers of Universal AAV Immuno-Gene Therapy for Cancer, today announced that it will present new scientific data at the 2025 American Society of Gene and Cell Therapy ...

NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...

April 30, 2025--(BUSINESS WIRE)--PanGIA Biotech, a company advancing urine-based ... using urine-based liquid biopsy (Abstract #3080), has been accepted for presentation in the poster session titled ...